# Clinical Pathways DemDx

Product partnership announcement single image showcasing Titanverse integration with DemDx for clinical pathways. Positions DemDx-powered clinical pathways as globally recognized, clinically trusted, and evidence-based solution built into consultation flow.

## Primary Asset

- Single image (product partnership announcement)

## Supporting Assets

- LinkedIn post

## Strategic Note

Partnership announcement effectively communicated DemDx integration. Moderate engagement (5.6% engagement rate, 3.1% CTR) indicates interest in clinical pathways partnership. Comment from Dr Lorin Gresser (CEO, DemDx) validates partnership and provides social proof. High reposts (7) indicate content was valuable for sharing. Partnership messaging successfully positioned clinical pathways as solution to tab-hopping and scattered SOPs.

---

## Campaign Overview

**Published:** November 29, 2025  
**Product:** Titanverse  
**Type:** Product Partnership  
**Purpose:** Announce Titanverse partnership with DemDx for clinical pathways integration, positioning DemDx-powered clinical pathways as globally recognized, clinically trusted, and evidence-based solution built into consultation flow.

## Core Message

Clinical pathways powered by DemDx and trusted by doctors worldwide are built into your consult flow. Less tab-hopping. More clarity. Safer care.

## Performance Highlights

**LinkedIn Single Image:**
- Impressions: 1,000
- Reach: 630
- Total Engagements: 56
- Engagement Rate: 5.6%
- Clicks: 31
- Click-Through Rate: 3.1%
- Reactions: 17
- Comments: 1
- Reposts: 7
- Page Viewers: 3
- Followers Gained: 0

## Campaign Assets

### Content
- **Primary Asset:** `content/single-image/image-01.md` - Partnership announcement visual

### Social Media Posts
- **LinkedIn:** `social/linkedin/2025-11-29-clinical-pathways-demdx/` - Posted November 29, 2025

## Structure

```
2025-11-29-clinical-pathways-demdx/
├── content/
│   └── single-image/
│       └── image-01.md
├── social/
│   └── linkedin/
│       └── 2025-11-29-clinical-pathways-demdx/
│           ├── caption.md
│           ├── comments.md
│           ├── metrics.json
│           └── meta.json
├── performance/
│   ├── linkedin.json
│   ├── tiktok.json
│   └── youtube.json
└── post-mortem.md
```

## Notes

- Product partnership announcement
- DemDx integration showcase
- Moderate engagement: 5.6% engagement rate, 3.1% CTR
- High reposts: 7 reposts indicate content was valuable for sharing
- Comment from DemDx CEO validates partnership
